Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06078956 · ClinicalTrials.gov registry record · NA
ABL90 Flex Plus Method Comparison Study_Adults
A NA study, sponsored by Radiometer Medical ApS.
- Completed
- Registry status
- NA
- Development phase
- 754
- Enrollment target
NCT06078956: Completed NA study, sponsored by Radiometer Medical ApS.
NCT06078956 is a NA study that has completed, run by Radiometer Medical ApS. The registered enrollment target is 754 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (46% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06078956, a NA study, has completed, sponsored by Radiometer Medical ApS.
- COMPLETED
- Registry status
- NA
- Development phase
- 754 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to validate performance claims for method comparison for the ABL90 FLEX PLUS for pH, pCO2, pO2, cCa2+, cCl-, cK+, cNa+, cGlu, cLac, ctHb, sO2, FO2Hb, FMetHb, FCOHb and FHHb in heparinized whole blood in a Point of Care (POC) setting.
Primary Outcome
Primary Endpoints: Slope, R\^2 and bias at medical decision points for each combination of modes and sample type, across sites
Interventions
- DEVICE Measuring of analytes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 754 participants |
| Start Date | 2023-07-08 |
| Est. Completion | 2025-01-31 |
| Phase | NA |
What the finished NCT06078956 record still lists
NCT06078956 is an interventional study that assigns participants to a tested intervention. The registered 754 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (46% lower).
The record links to 0 conditions, and to 1 intervention - of which Measuring of analytes is the first listed.
NCT06078956 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06078956 about?
NCT06078956 is a clinical study titled "ABL90 Flex Plus Method Comparison Study_Adults". The goal of this clinical trial is to validate performance claims for method comparison for the ABL90 FLEX PLUS for pH, pCO2, pO2, cCa2+, cCl-, cK+, cNa+, cGlu, cLac, ctHb, sO2, FO2Hb, FMetHb, FCOHb and FHHb in heparinized whole blood in a Point of Care (POC) setting.
What is the current status of trial NCT06078956?
This trial is currently completed. It is a NA study. The enrollment target is 754 participants. The study started on 2023-07-08. Estimated completion is 2025-01-31.
What interventions are being tested in trial NCT06078956?
The interventions under investigation include: Measuring of analytes (DEVICE).
Who is sponsoring clinical trial NCT06078956?
This trial is sponsored by Radiometer Medical ApS, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06078956's enrollment target sits among peer trials
754 145th of 2000 higher than 1,856 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05379985 · 754 participants · Phase 1
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- NCT05427370 · 754 participants · NA
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
- NCT05869149 · 756 participants · NA
Systems Science Approaches to Improve Access to Healthier Foods: The FRESH Trial
- NCT06095583 · 756 participants · Phase 3
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI